Is R(2)* a New MRI Biomarker for the Progression of Parkinson’s Disease? A Longitudinal Follow-Up

PURPOSE: To study changes of iron content in basal ganglia in Parkinson’s disease (PD) through a three-year longitudinal follow-up of the effective transverse relaxation rate R(2)*, a validated MRI marker of brain iron content which can be rapidly measured under clinical conditions. METHODS: Twenty-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulla, Miguel, Bonny, Jean Marie, Ouchchane, Lemlih, Rieu, Isabelle, Claise, Beatrice, Durif, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585727/
https://www.ncbi.nlm.nih.gov/pubmed/23469252
http://dx.doi.org/10.1371/journal.pone.0057904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585727/
https://www.ncbi.nlm.nih.gov/pubmed/23469252
http://dx.doi.org/10.1371/journal.pone.0057904

Ejemplares similares